Rash including mucosal involvement: Case definition and guidelines for collection, analysis, and presentation of immunization safety data

Vaccine

Volumn 25, Issue 31, 2007, Pages 5697-5706

  Beigel, John ^a   Kohl, Katrin S ^b   Khuri Bulos, Najwa ^c   Bravo, Lulu ^d   Nell, Patricia ^e   Marcy, S Michael ^f   Warschaw, Karen ^g   Ong Lim, Anna ^d   Poerschke, Gabriele ^h   Weston, William ⁱ   Lindstrom, Jill A ^j   Stoltman, Gillian ^k   Maurer, Toby ^l  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c JORDAN UNIVERSITY HOSPITAL   (Jordan)

^d UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^e USAF   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g MAYO CLINIC   (United States)

^h Global Medical Affairs Merck Sharp Dohme China   (China)

ⁱ UNIVERSITY OF COLORADO   (United States)

^j CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^k MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Adverse event; Case definition; Guidelines; Immunization; Mucocutaneous; Rash

Indexed keywords

VACCINE;

ARTICLE; CASE DEFINITION; CASE STUDY; CLINICAL PRACTICE; CLINICAL RESEARCH; DATA ANALYSIS; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEVER; HUMAN; IMMUNIZATION; INJECTION SITE REACTION; MUCOSA; POSTMARKETING SURVEILLANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; SKIN; STANDARD;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; EXANTHEMA; HUMANS; IMMUNIZATION; MUCOUS MEMBRANE; SAFETY; TERMINOLOGY;

EID: 34447269472     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.02.066     Document Type: Article

References (10)

1. Zhou W., Pool V., Iskander J.K., English-Bullard R., Ball R., Wise R.P., et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS), United States, 1991-2001. Morb Mortal Wkly Rep 52 (2003) 1-24
2. Anderson K., Anderson L.E., and Glanze W.D. Mosby's medical, nursing, and allied health dictionary (1998), Mosby, St. Louis, MO
3. Stedman, and Lathrop T. Stedman's medical dictionary. 27th ed. (2000), Lippincott Williams & Wilkins, Baltimore
4. In: Bolognia, Jorrizo, and Rapini (Eds). Dermatology (2003), Mosby (Elsevier), London
5. In: Freedberg, Eisen, Wolff, Austen, Goldsmith, and Katz (Eds). Fitzpatrick's dermatology in general medicine. 6e (2003), McGraw-Hill, New York
6. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH). Guidelines for clinical safety assessment (E2a-e). Available on the World Wide Web: http://www.ich.org/ [last accessed February 9, 2006].
7. Council for International Organizations of Medical Sciences (CIOMS). Reporting form for international reporting of adverse drug reactions. Available on the World Wide Web: http://www.cioms.ch/frame_what_is_cioms.htm [last accessed February 9, 2006].
8. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285(15):1987-91. Available on the World Wide Web: http://www.consort-statement.org/Statement/revisedstatement.htm [last accessed February 9, 2006].
9. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., and Stroup D.F. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 354 9193 (1999) 1896-1900. http://www.consort-statement.org/Initiatives/complements.htm [last accessed February 9, 2006]
10. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 283 15 (2000) 2008-2012. http://www.consort-statement.org/Initiatives/complements.htm [last accessed February 9, 2006]